News & Updates

Inebilizumab helps prevent flare-ups in IgG4-related disease

07 May 2025

CD19-targeted B-cell depletion with inebilizumab appears to reduce the risk of flares and increase the likelihood of flare-free complete remission at 1 year in patients with IgG4-related disease, according to the phase III MITIGATE trial.

Inebilizumab helps prevent flare-ups in IgG4-related disease

07 May 2025

Rapid point-of-care testing enables timely and targeted RTI treatment

07 May 2025

According to the 2021 Global Burden of Disease (GBD) study, COVID-19 and lower respiratory tract infections (LRTIs) ranked as the 1st and 5th leading causes of global disease burden across all age groups and genders.

Rapid point-of-care tests (POCTs) enable timely diagnosis, particularly in vulnerable populations at higher risk of severe illness, complications, and hospitalization.

Rapid point-of-care testing enables timely and targeted RTI treatment

07 May 2025

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

07 May 2025 by

Adding pembrolizumab to concurrent chemoradiotherapy (CCRT) improves progression-free survival (PFS) and overall survival (OS) in patients with high-risk, locally advanced cervical cancer (LACC) compared with CCRT alone, according to the second interim analysis of the phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial presented at SGO 2025.

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

07 May 2025

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025 by

A single dose of adjuvanted respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVPreF3 OA) is efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) over three RSV seasons in older adults aged ≥60 years, according to results of the phase III AReSVi-006 trial presented at ESCMID Global 2025.

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025

Cancer therapy takes a toll on women’s sexual health

06 May 2025 by

In women being treated for cervical cancer, chemotherapy and radiotherapy appear to have a substantial and lasting negative effect on sexual health, including satisfaction and desire, as shown in a descriptive cross-sectional study conducted in Brazil.

Cancer therapy takes a toll on women’s sexual health

06 May 2025

Which factors predict regret after urinary reconstruction in spinal cord injury patients?

06 May 2025

Lower urinary tract reconstruction remains a well-accepted approach for managing refractory neurogenic bladder in patients with spinal cord injury, but decision regret persists for some.

Which factors predict regret after urinary reconstruction in spinal cord injury patients?

06 May 2025

$AI boasts accurate fracture detection in ED radiographs$

AI boasts accurate fracture detection in ED radiographs

06 May 2025 by

An artificial intelligence (AI) solution (RBfracture) has demonstrated high accuracy and similar sensitivity to human radiologists in diagnosing fractures on appendicular and pelvic radiographs in the emergency department (ED), reports a study in Singapore.

AI boasts accurate fracture detection in ED radiographs

06 May 2025

Testosterone may protect against effects of gender-related discrimination

06 May 2025

Testosterone appears to provide protective benefits against the negative impact of gender-related discrimination on well-being among LGBTQ+ individuals, suggests a recent study.

Testosterone may protect against effects of gender-related discrimination

06 May 2025

SG cancer care model continues to gain traction

06 May 2025 by

In Singapore, NCIS* on-the-go (NOTG) – a network of community cancer treatment clinics within 20 km of the hospital – draws out workload from the NUH** NCIS Cancer Centre, with a high patient satisfaction rate and significant time and cost savings.

SG cancer care model continues to gain traction

06 May 2025

Single primaquine dose helps block malaria transmission in children

06 May 2025

A single low primaquine dose appears to safely and efficaciously reduce transmission of Plasmodium falciparum in children, according to the results of a meta-analysis.

Single primaquine dose helps block malaria transmission in children

06 May 2025

News & Updates

Filter by Specialty:

Specialty:

Inebilizumab helps prevent flare-ups in IgG4-related disease

Inebilizumab helps prevent flare-ups in IgG4-related disease

Rapid point-of-care testing enables timely and targeted RTI treatment

Rapid point-of-care testing enables timely and targeted RTI treatment

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

Pembrolizumab plus CCRT improves survival in locally advanced cervical cancer

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Cancer therapy takes a toll on women’s sexual health

Cancer therapy takes a toll on women’s sexual health

Which factors predict regret after urinary reconstruction in spinal cord injury patients?

Which factors predict regret after urinary reconstruction in spinal cord injury patients?

AI boasts accurate fracture detection in ED radiographs

AI boasts accurate fracture detection in ED radiographs

Testosterone may protect against effects of gender-related discrimination

Testosterone may protect against effects of gender-related discrimination

SG cancer care model continues to gain traction

SG cancer care model continues to gain traction

Single primaquine dose helps block malaria transmission in children

Single primaquine dose helps block malaria transmission in children